Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.

Chertova, Elena; Crise, Bruce J; Morcock, David R; Bess, Julian W; Henderson, Louis E; Lifson, Jeffrey D

Chertova, Elena; Crise, Bruce J; Morcock, David R; Bess, Julian W; Henderson, Louis E; Lifson, Jeffrey D.

Affiliation

Chertova E; AIDS Vaccine Program, SAIC Frederick, National Cancer Institute at Frederick, Building 535, Fifth Floor, Frederick, MD 21702, USA.

Curr Mol Med ; 3(3): 265-72, 2003 May.

Article in En | MEDLINE | ID: mdl-12699362

Subject(s)

2,2'-Dipyridyl/analogs & derivatives; HIV-1/metabolism; Simian Immunodeficiency Virus/metabolism; Sulfhydryl Reagents/pharmacology; Viral Proteins/metabolism; Virion/immunology; Virus Inactivation; 2,2'-Dipyridyl/pharmacology; Animals; DNA, Viral; Disulfides/pharmacology; Glutathione/metabolism; HIV-1/drug effects; HIV-1/genetics; HIV-1/immunology; Nucleocapsid Proteins/metabolism; Simian Immunodeficiency Virus/drug effects; Simian Immunodeficiency Virus/genetics; Simian Immunodeficiency Virus/immunology; Virion/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfhydryl Reagents / Viral Proteins / Virion / 2,2'-Dipyridyl / HIV-1 / Simian Immunodeficiency Virus / Virus Inactivation Limits: Animals Language: En Journal: Curr Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2003 Document type: Article Affiliation country: United States Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links